Apple Watch Series 9 and Ultra 2 Lose Blood Oxygen Sensor Amid Patent Dispute
The Apple Watch has hit a roadblock at the start of the new year, as a patent dispute with medical tech firm Masimo has forced Apple to disable the blood oxygen sensor in their latest models, the Apple Watch Series 9 and Apple Watch Ultra 2. This setback comes as a surprise, considering Apple’s reputation for its financial prowess and technological innovation. However, CEO Tim Cook remains optimistic about the future of their smartwatches, urging customers not to hesitate in purchasing them.
In a recent interview with CNBC, Cook defended the Apple Watch, stating that there are still plenty of reasons to buy it, even without the blood oxygen sensor. And he’s not wrong. The Apple Watch has consistently been regarded as one of the best smartwatches on the market, offering a plethora of cutting-edge features that set it apart from its competitors. While the absence of the blood oxygen monitor may be disappointing to some, it doesn’t diminish the overall appeal and functionality of the device.
Nevertheless, it is peculiar to see the CEO of a company like Apple having to justify the purchase of one of their flagship products. This could be attributed to the mounting pressure from the ongoing patent dispute with Masimo. The lack of resolution in this legal battle suggests that it may drag on for months or even longer. As a result, Apple’s blood oxygen monitor could remain absent from their watches for an extended period.
For those who were specifically interested in the blood oxygen sensor, this news may dampen their enthusiasm. While there are numerous other compelling features to consider when buying an Apple Watch, the absence of this particular function limits their options. However, all hope is not lost. Although Apple is prohibited from selling watches with the blood oxygen sensor, third-party retailers like Amazon and Best Buy can continue to sell their existing stock. Therefore, if this feature is a must-have for you, you can still find Apple Watches with the blood oxygen monitor through these alternative channels.
In conclusion, despite the setback caused by the patent dispute, the Apple Watch remains a top contender in the smartwatch market. While the absence of the blood oxygen sensor may disappoint some potential buyers, there are still plenty of reasons to consider purchasing an Apple Watch. With its exceptional features and reputation for quality, it continues to be a popular choice among consumers. As for the ongoing legal battle, only time will tell how it will impact the future of Apple’s smartwatches.